List of Berg (company) patents | 6 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9896731 Methods for treatment of oncological disorders using an epimetabolic shifter (coenzyme Q10)	Patent 9896731 was granted and assigned to Berg (company) on February, 2018 by the United States Patent and Trademark Office.	Berg (company)	Berg (company)	United States Patent and Trademark Office	9896731	February 20, 2018
‌ US Patent 9797905 Use of markers in the diagnosis and treatment of prostate cancer	Patent 9797905 was granted and assigned to Berg (company) on October, 2017 by the United States Patent and Trademark Office.	Berg (company)	Berg (company)	United States Patent and Trademark Office	9797905	October 24, 2017
‌ US Patent 9886545 Interrogatory cell-based assays and uses thereof	Patent 9886545 was granted and assigned to Berg (company) on February, 2018 by the United States Patent and Trademark Office.		Berg (company)	United States Patent and Trademark Office	9886545	February 6, 2018
‌ US Patent 9901637 Vitamin D3 and analogs thereof for treating alopecia	Patent 9901637 was granted and assigned to Berg (company) on February, 2018 by the United States Patent and Trademark Office.		Berg (company)	United States Patent and Trademark Office	9901637	February 27, 2018
‌ US Patent 9901542 Methods of treatment of cancer by continuous infusion of coenzyme Q10	Patent 9901542 was granted and assigned to Berg (company) on February, 2018 by the United States Patent and Trademark Office.	Berg (company)	Berg (company)	United States Patent and Trademark Office	9901542	February 27, 2018
‌ US Patent 10023864 Methods of treating a metabolic syndrome by modulating heat shock protein (HSP) 90-beta	Patent 10023864 was granted and assigned to Berg (company) on July, 2018 by the United States Patent and Trademark Office.	Berg (company)	Berg (company)	United States Patent and Trademark Office	10023864	July 17, 2018